Nanobiotix (NBTX) Total Current Liabilities: 2019-2025
- Nanobiotix's Total Current Liabilities rose 17.24% to $71.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.4 million, marking a year-over-year increase of 17.24%. This contributed to the annual value of $63.0 million for FY2024, which is 16.74% up from last year.
- According to the latest figures from Q2 2025, Nanobiotix's Total Current Liabilities is $71.4 million, which was up 13.30% from $63.0 million recorded in Q4 2024.
- Over the past 5 years, Nanobiotix's Total Current Liabilities peaked at $71.4 million during Q2 2025, and registered a low of $42.1 million during Q4 2021.
- In the last 3 years, Nanobiotix's Total Current Liabilities had a median value of $60.9 million in 2024 and averaged $60.6 million.
- As far as peak fluctuations go, Nanobiotix's Total Current Liabilities skyrocketed by 85.66% in 2021, and later dropped by 0.81% in 2022.
- Over the past 5 years, Nanobiotix's Total Current Liabilities (Quarterly) stood at $42.1 million in 2021, then decreased by 0.81% to $45.4 million in 2022, then rose by 19.48% to $53.7 million in 2023, then increased by 17.36% to $63.0 million in 2024, then rose by 17.24% to $71.4 million in 2025.
- Its Total Current Liabilities was $71.4 million in Q2 2025, compared to $63.0 million in Q4 2024 and $60.9 million in Q2 2024.
